Key facts
- This page summarizes Robin Kramer's Form 4 filing for BIOGEN INC. (BIIB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Dec 2023, 17:02.
Robin Kramer - 08 Dec 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Chief Accounting Officer
- Issuer ticker
- BIIB
- Reported as of
- 08 Dec 2023
- Net transaction value
- -$40,679
- SEC form
- 4
- Accepted by SEC
- 12 Dec 2023, 17:02:39 UTC
- Prior SEC filing
- 05 Jul 2023
- Next SEC filing
- 26 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, attorney-in-fact for Robin Kramer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robin Kramer filed Form 4 for BIOGEN INC. (BIIB) on 12 Dec 2023.
Change
- Previous filing in this sequence was filed on 05 Jul 2023.
- Current net transaction value: -$40,679.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +351
- Change %
- +8.8%
- Price
- $0.000000
- Shares after
- 4,325
- Date
- 08 Dec 2023
- Ownership
- Direct
BIIB
transaction
Common Stock
Tax liability
- Transaction value
- $40,679
- Shares
- -170
- Change %
- -3.9%
- Price
- $239.29
- Shares after
- 4,155
- Date
- 08 Dec 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIIB
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -351
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 351
- Date
- 08 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 351
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021.